Revolutionizing Drug Discovery with AI-generated Biologics

This chapter explores the use of AI in creating high affinity biologics for drug discovery, discussing the evolution of AI models and their impact on designing customized biologics with specific attributes. It highlights the integration of AI with wet lab processes through acquisitions, enabling breakthroughs in target discovery and antibody design. The chapter also delves into specific projects, such as developing a drug candidate targeting TL1A for inflammatory bowel disease using AI to accelerate timelines and reduce costs.